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Rectal bleeding and colorectal cancer
Inclusion criteria of study need
clarification
Editor—Wauters et al report on the
diagnostic value of rectal bleeding in terms
of subsequent development of colorectal
cancer.1 We feel that this study requires clari›
fication for several reasons.
Firstly, the authors do not report the
pre›test probability of colorectal cancer in
age specific categories in their population.
The diagnostic value of a symptom such as
rectal bleeding and the impact on post›test
probability and subsequent referral thresh›
old are maximised when the pre›test
probability of the disease is known.2
Secondly, they fail to mention that less
than half of patients with rectal bleeding
have no other symptoms.3 More often it is
associated with other bowel symptoms that
have higher diagnostic value than rectal
bleeding alone.4
Thirdly, the reported positive likelihood
ratio of 68.3 “rules in” a diagnosis of
colorectal cancer, irrespective of the pre›test
probability of the disease.2 The reported
specificity of 99.5% has the same effect of
ruling in the target disorder of colorectal
cancer. These findings imply that any
patients attending their general practitioner
with rectal bleeding need referral and
further evaluation. Our own clinical experi›
ence and other community based studies of
rectal bleeding indicate that such a high spe›
cificity and likelihood ratio is unlikely and
may well be misleading.4 5
Finally, the most likely explanation for
the results relates to general practitioners
underreporting rectal bleeding in the
prospective arm of the study. Wauters et al
chose “rectal bleeding as the reason for visit›
ing a general practitioner” as the inclusion
criterion for their study. They should clarify
whether this means that patients in whom
rectal bleeding was not the primary reason
for consulting their general practitioner
were excluded. A prospective study in the
Netherlands showed that among patients
presenting with rectal bleeding, 51% stated
this as the primary reason for consulting
their general practitioner; 49% consulted for
a different reason, but rectal blood loss was
subsequently mentioned during the consul›
tation.4 Another prospective study found
that 3% (95% confidence interval 1.4% to
5.8%) of patients with rectal bleeding subse›
quently developed colorectal cancer, and
even in this study patients with “clinically
relevant rectal bleeding” were overrepre›
sented.5 In Wauters et al’s study, 27 patients
with rectal bleeding (7%, 4.6% to 10%)
developed colorectal cancer.
In summary, there may have been a sys›
tematic bias in excluding less severe forms of
rectal bleeding which may have not been the
primary reason for consulting a general
practitioner. This has resulted in inflated
values for specificity and positive likelihood
ratio. Before their results are incorporated
into clinical practice Wauters et al should
clarify their inclusion criteria and provide
age specific two by two tables so that readers
can judge for themselves the diagnostic
value of isolated rectal bleeding in general
practice.
Tom Fahey senior lecturer in general practice
tom.fahey@bristol.ac.uk
Alan Montgomery MRC training fellow
Knut Schroeder MRC training fellow
Division of Primary Health Care, University of
Bristol, Bristol BS8 2PR
1 Wauters H, Van Casteren V, Buntinx F. Rectal bleeding and
colorectal cancer in general practice: diagnostic study.BMJ
2000;321:998›9. (21 October.)
2 Black ER, Bordley D, Tape TG, Panzer RJ. Diagnostic
strategies for common medical problems. Philadelphia:
American College of Physicians, 1999.
3 Douek M, Wickramasinghe M, Clifton MA. Does isolated
rectal bleeding suggest colorectal cancer? Lancet
1993;354:393.
4 Fijten GH, Starmans R, Muris JW, Schouten HJ, Blijham
GH, Knottnerus JA. Predictive value of signs and
symptoms for colorectal cancer in patients with rectal
bleeding in general practice. Fam Pract 1995;12:279›86.
5 Fijten GH, Muris JW, Starmans R, Knottnerus JA, Blijham
GH, Krebber TF. The incidence and outcome of rectal
bleeding in general practice. Fam Pract 1993;10:283›7.
Results of study were incorrectly
interpreted
Editor—The diagnosis of colorectal cancer
is an important subject, but the paper by
Wauters et al is flawed on several counts.1
To determine the value of rectal
bleeding in the diagnosis of colorectal
cancer the authors correctly analysed retro›
spectively all patients with a diagnosis of
colorectal cancer in 1993›4 to calculate the
sensitivity and analysed prospectively all
patients presenting with rectal bleeding in
1993›4 to calculate the positive predictive
value. They then claim to have estimated the
specificity and negative predictive values
from these results. However, the retrospec›
tive and prospective parts of the study were
carried out on different populations of
patients, and the data collected did not give
a measure of the relative size of the popula›
tion who neither had colorectal cancer nor
presented with rectal bleeding. Hence it was
not possible to make valid estimates of the
specificity and negative predictive values. For
the same reasons, valid estimates of the like›
lihood ratios cannot be made.
The authors stated that the probability
of colorectal cancer increases greatly in
association with fatigue and weight loss.
However, the figure of 7.1% for the positive
predictive value associated with fatigue must
be wrong as the mean is outside the 95%
confidence interval (8.3% to 15.8%). The
positive predictive value associated with
weight loss of 16.0% (4.5% to 36.1%) is not
statistically different from the overall posi›
tive predictive value of 7.0%.
The authors argued that “people should
be better informed and encouraged to seek
medical advice if bleeding occurs.”1
Although this advice might be appropriate,
the conclusion was not justified by their
results, which did not show that any of the
patients failed to seek appropriate medical
advice.
Wai›Ching Leung senior registrar in public health
medicine
Epidemiology and Public Health, Newcastle
General Hospital, Newcastle NE4 6BE
wai_chingleung@hotmail.com
1 Wauters H, Van Casteren V, Buntinx F. Rectal bleeding and
colorectal cancer in general practice: diagnostic study.BMJ
2000;321:998›9. (21 October.)
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Authors’ reply
Editor—We present some additional infor›
mation that could not be included in the
short report.
The pre›test probability of colorectal
cancer in our population was 63 per
100 000 patient years; for the age groups
< 50, 50›59, 60›69, 70›79, and > 80 it was 3,
72, 162, 296, and 401 respectively. These fig›
ures are largely similar to the incidences
found by the regional cancer registry.1
We registered additional signs and
symptoms that contribute to the diagnosis of
colorectal cancer. The positive predictive
values of the association of rectal bleeding
and each factor are presented in the table.
The positive predictive value for anal blood
loss without any additional symptom was
4.4%.
The likelihood of cancer in a patient
with anal blood loss is represented by the
(age specific) positive predictive value and
not by the likelihood ratio. The latter gives
an indication of the increase of the odds of
cancer by the emergence of the symptom.
The positive predictive value is low (0.7%)
below age 50, but increases in older patients,
leading to both the conclusion that rectal
bleeding should prompt referral in these
age groups and a high overall positive likeli›
hood ratio. Similar reasoning applies to the
specificity.
Fijten et al found that rectal bleeding is
underreported by both patients and physi›
cians.2 This may also have occurred in our
study. However, we only studied rectal bleed›
ing presented to the general practitioner.
General practitioners were instructed to
register all cases of rectal bleeding, whether
or not this was the main reason for the con›
sultation. Prospectively, rectal bleeding was
the main reason for consultation in 56/386
(15%) cases, even less than was found by
Fijten.2 This does not support the fears of
Fahey et al.
Leung correctly states that sensitivity
and positive predictive value were directly
identified from our data but specificity and
negative predictive value only indirectly
from the two by two table based on the data
resulting from both arms of the study. As it
was impossible to perform invasive tests in
all patients visiting their general prac›
titioner, we opted for a follow up period as a
reference standard. The use of two arms
within one study is then the only option. The
combination of the resulting time shift and
possible recall bias results in a small
difference in the left upper cell of the two by
two table (27 in the prospective arm and 31
in the retrospective arm). However, this
difference does not affect the results of our
calculations.
Finally, we concluded from our data that
most cases of rectal bleeding do not require
referral in connection with possible colorec›
tal cancer. This does not apply, however, to
patients aged over 60 or to those with addi›
tional signs or symptoms. These conclusions
still hold.
Frank Buntinx professor
frank.buntinx@med.kuleuven.ac.be
Hans Wauters general practitioner
Department of General Practice, Catholic
University of Leuven, B 3000 Leuven, Belgium
Viviane Van Casteren epidemiologist
Department of Epidemiology, Scientific Institute of
Public Health, B1050 Brussels
1 Buntinx F, Cloes E, Dhollander D, Lousbergh D, Op de
Beeck L, Rummens JL, et al. Incidence of cancer in the Belgian
province of Limburg in 1996›1998. Hasselt: Limburg Cancer
Registery, 2000.
2 Fijten G, Muris J, Starmans R, Knottnerus JA, Blijham G,
Krebber T. The incidence and outcome of rectal bleeding
in general practice. Fam Pract 1993;10:283›7.
All epidemiological evidence is
important in colorectal cancer
Editor—Boyle and Langman summarised
descriptive features and risk factors of color›
ectal cancer in their article.1 They seem,
however, rather selective (or not well
informed) of recent literature regarding
dietary and nutritional factors in the
aetiology of colorectal cancer. Boyle and
Langman state that the intake of dietary fat
and meat is positively related to risk of
colorectal cancer. A high intake of meat is
probably associated with increased risk of
colorectal cancer, but the epidemiological
evidence for fat and colorectal cancer is not
as strong as they say. They referred in detail
to the results in the nurses’ health study
published by Willett et al in 1990,2 a single
prospective study that showed an increased
risk of colon cancer associated with high
intake of total or animal fat after adjustment
for total calorie intake.
Epidemiological evidence should not be
relied on from the result of a single study,
but the total evidence must be considered.
At least seven large prospective studies were
reported in Europe and the United States
up till 1999. None of these studies found a
clear, positive association between fat and
colon or colorectal cancer; reported relative
risks for the highest versus lowest intake
ranged from 0.5 to 1.2 with adjustment for
total calorie intake. Six of these studies also
addressed the relation between saturated fat
and colorectal cancer and found no material
association, with relative risks of 0.7›1.4 for
the highest versus lowest intake. Giovan›
nucci et al noted that the increased risk
associated with animal fat intake in the
American nurses disappeared when red
meat intake was taken into account.3
Furthermore, in the combined analysis of 13
case›control studies, Howe et al showed no
measurable positive association between
either total fat intake or intake of saturated
fat and colon cancer with adjustment for
total calorie intake.4 While animal studies
have suggested an aetiological role for high
fat intake in colorectal carcinogenesis, such
evidence is very hard to extrapolate to
humans living freely.
Boyle and Langman also say that both
vegetables and fruits may be protective
against colorectal cancer. There is, however,
little evidence regarding the protective effect
of fruit against colorectal cancer; readers will
relish a more accurate and succinct review
article regarding dietary factors and colorec›
tal cancer,5 which Boyle and Langman
missed in the list of further readings.
Suminori Kono professor of preventive medicine
Kyushu University Faculty of Medicine, Fukuoka
812›8582, Japan
skono@phealth.med.kyushu›u.ac.jp
Competing interests: None declared.
1 Boyle P, Langman JS. ABC of colorectal cancer: Epidemi›
ology. BMJ 2000;321:805›8. (30 September.)
2 Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer
FE. Relation of meat, fat, and fiber intake to the risk of
colon cancer in a prospective study among women. N Engl
J Med 1990;323:1664›72.
3 Giovannucci E, Rim EB, Stampfer MJ, Colditz GA, Asche›
rio A, Willett WC. Intake of fat, meat, and fiber in relation
to risk of colon cancer in men. Cancer Res 1994;54:2390›7.
4 Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J,
Duffy S, et al. The relationship between dietary fat intake
and risk of colorectal cancer: evidence from the combined
analysis of 13 case›control studies. Cancer Causes Control
1997; 8:215›28.
5 World Cancer Research Fund, American Institute for Can›
cer Research. Food, nutrition and the prevention of cancer: a
global perspective. Washington, DC: American Institute for
Cancer Research, 1997.
Impact of NHS Direct on
demand for immediate care
NHS Direct must be better marketed and
deal with problems more effectively
Editor—In their responses to the paper by
Munro et al,1 who found that NHS Direct
had no appreciable impact on the use of
ambulance services and accident and emer›
gency departments, McInerney et al2 and
Lawson et al3 addressed two important
points: do the patients know about NHS
Direct; and does NHS Direct make any
difference to the use of emergency services
anyway? At the moment, the answer to both
questions seems to be “no.”
We are studying consultations with our
out of hours general practitioners’ coopera›
tive (Bridgwater Out›of›hours and Night
Emergency Service, BONES), comparing
the outcomes for two groups of patients who
have called our service: those who have pre›
viously contacted NHS Direct about their
problem and those who have not.
Preliminary results show that, of the
1153 consultations with BONES over four
weeks in October, in 1005 cases (87%) the
patients said they had not tried NHS Direct.
We had a similar number of contacts over
the same period in 1997, before NHS Direct
became operational. Even if NHS Direct is
preventing a small upward trend in calls out
Positive predictive values of rectal bleeding and
associated symptoms for diagnosis of colorectal
cancer
Associated
symptom
Rectal bleeding
Positive predictive
value (95% CI)
All
patients
Patients with
colorectal
cancer
Pain 34 0 0 (0 to 10.2)
Spasms 111 6 5.4 (2.0 to 11.3)
Fatigue 70 5 7.1 (2.3 to 15.8)
Weight loss 25 4 16.0 (4.5 to 36.0)
Palpable
tumour
19 6 31.5 (12.5 to 56.5)
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of hours,1 the fact therefore remains that
most patients do not use NHS Direct.
But would it make any difference to the
outcome if they did? The purpose of NHS
Direct is to deal effectively with problems
that can be dealt with on the telephone, and
pass on to the emergency services those
problems that are likely to need some kind
of intervention. Therefore, those who call
NHS Direct and then consult the emergency
services should end up needing more face to
face consultations, on the spot treatment,
visits, and hospital admissions, and fewer
consultations by telephone alone. On the
contrary, we found that 53% of the problems
that had already been presented to NHS
Direct could still be dealt with over the tele›
phone by BONES, compared with 47% of
those that had not involved NHS Direct.
Furthermore, the NHS Direct callers
ended up needing fewer treatments or
admissions to hospital. NHS Direct has the
potential to alleviate some of the increasing
demands on primary care, both in and out
of hours, but if the government wants it to be
useful it must be better marketed and must
deal more effectively with the problems pre›
sented to it.
Peter Aird general practitioner
Paul Hansford general practitioner
Richard O’Brien general practitioner
RichardAOB@aol.com
Elizabeth Parfitt research co›ordinator
Hilary Swindall general practitioner
East Quay Medical Centre, Bridgwater, Somerset
TA6 5YB
1 Munro J, Nicholl J, O’Cathain A, Knowles E. Impact of
NHS Direct on demand for immediate care: observational
study. BMJ 2000;321:150›3. (15 July.)
2 McInerney J, Chillala S, Read C, Evans A. Impact of NHS
Direct on demand for immediate care. BMJ 2000;321:
1077. (28 October.)
3 Lawson G, Furness J, Santosh S, Armstrong S. Impact of
NHS Direct on demand for immediate care. BMJ 2000;
321:1077. (28 October.)
Meaningful review is still outstanding
Editor—The comments by Munro et al and
the responses by McInerney et al and
Lawson et al relate to a time when the
volume of calls to NHS Direct and their
impact were very small.1 2–3 Today three
different structures to NHS Direct remain,
pending the adoption of the NHS clinical
assessment system this year. A meaningful
review of a whole service, therefore, is still a
way off.
Clinicians participating in NHS Direct
see the profound changes that can come
from the application of decision support
logic to historical models of care. To others it
remains outside their experience, and its
first application (NHS Direct) seems a costly
irrelevance. The vision of our professional
leaders has remained focused on the politics
of NHS Direct rather than its clinical poten›
tial.
The north east site has piloted inte›
grated care out of hours since July 1999.
Recent comparative data for two large areas
of the integrated cooperative (Northern
Doctors Urgent Care) and adjacent accident
and emergency departments are shown in
the table. The brief is to improve patient
access and appropriate direction, but it is
reassuring that NHS Direct apparently does
not accelerate acute demand as the volume
of calls grows.
Domestic visiting rates for the coopera›
tive (12.1%) are half the rates before integra›
tion. For every two patients referred to a
higher level of care, three are directed to a
lower level of intervention.4 Patient satisfac›
tion is over 90%, yet 72% are diverted from
their original intention and many no longer
see doctors. All this, while the service is still
in its infancy.
The NHS clinical assessment system
piloted by NHS Direct will produce impor›
tant changes in the behaviour of patients
and clinicians over time and outcome
studies of a high quality will be needed. The
partnership experiment is working, and
integrated acute care departments behind
the triage platform will be piloted next year.
Many teething troubles and a long way in a
short time for the NHS certainly, but “a
beleaguered service”? I don’t think so.
K McKenna medical director, NHS Direct Northeast
Bondgate Practice, Alnwick, Northumberland
NE66 2NL
mmck@globalnet.co.uk
1 Munro J, Nicholl J, O’Cathain A, Knowles E. Impact of
NHS Direct on demand for immediate care: observational
study. BMJ 2000;321 150›3. (15 July.)
2 McInerney J, Chillala S, Read C, Evans A. Impact of NHS
Direct on demand for immediate care. BMJ
2000;321:1077. (28 October.)
3 Lawson G, Furness J, Santosh S, Armstrong S. Impact of
NHS Direct on demand for immediate care. BMJ
2000;321:1077. (28 October.)
4 NHS Direct. Audit of patient satisfaction and outcome. North›
umberland Community Health Council, 2000.
NHS Direct can help accident and
emergency departments
Editor—McInerney et al found low aware›
ness of NHS Direct in patients attending
their accident and emergency department,
and wondered whether a proper national
publicity campaign would help.1 Such a
national campaign started on 20 November
to mark the service becoming available
throughout England. It would be worth
repeating their study after the campaign.
Replicating the study in other sites seems a
useful way to assess awareness among the
population. We intend to perform a similar
study in accident and emergency depart›
ments in Hampshire, where NHS Direct has
been established for 19 months.
Lawson et al have been unable to divert
telephone calls for clinical advice from their
accident and emergency department to
NHS Direct.2 Such a scheme has been in
place in Portsmouth for over a year now and
was recently extended to Southampton. As
Lawson et al noted, call diversion to NHS
Direct offers significant advantages in quality
of service, including staff trained specifically
in telephone advice, computerised proto›
cols, and improved documentation. It can
also increase time for direct patient contact.
In Portsmouth we estimate that the removal
of the need to respond to telephone calls
has freed up the equivalent of two whole
time equivalent senior nurses, enabling
them to improve the quality of service to
patients requiring face to face advice.
Along with other published evaluations,3
Lawson et al comment on the lack of impact
of NHS Direct on numbers attending estab›
lished healthcare services. Such evaluations
oversimplify the objectives of the service.
NHS Direct was set up to improve access to
healthcare services, which it has achieved,
with over 3 million callers to the service
already. Many callers indicate a prior
intention to call their general practitioner or
attend accident and emergency wards, and
yet they are advised about self care,
potentially saving a visit. It is, however,
evident that other callers would not other›
wise have accessed healthcare services.
Some of these patients, who would normally
fall “below the water level” of the “iceberg of
illness,”4 are advised to seek further clinical
advice and will thus move into the system.
The net numerical effect of these flows on
existing services may be neutral. But those
accessing services should be doing so more
appropriately. Evaluations of NHS Direct
must tackle this challenge of measuring
appropriateness. This is the third side of the
triangle of evaluation—increased access to
healthcare information and advice, and
demand on existing services being the
others.
Mike Sadler medical director
NHS Direct Hampshire and Isle of Wight,
Winchester SO22 5DH
mike.sadler@hants›iow.nhsdirect.nhs.uk
Mike Howell consultant in accident and emergency
Chris Cahill associate clinical director, accident and
emergency
Queen Alexandra Hospital, Portsmouth PO6 3LY
1 McInerney J, Chillala S, Read C, Evans A. Target
communities show poor awareness of NHS Direct. BMJ
2000;321:1077. (28 October.)
2 Lawson G, Furness J, Santosh S, Armstrong S. Impact of
NHS Direct on demand for immediate care. BMJ
2000;321:1077. (28 October.)
3 Munro J, Nicholl J, O’Cathain A, Knowles E. Impact of
NHS Direct on demand for immediate care: observational
study. BMJ 2000;321:150›3. (15 July.)
4 Hannay D. The symptom iceberg. London: Routledge and
Kegan Paul, 1979.
Comparative data for two of the largest areas of general practice cooperative and adjacent accident and
emergency departments in September 1999 and 2000
September 1999 September 2000 Percentage change
Out of hours contacts with two largest divisions of cooperative:
Telephone advice 1 048 712 −32.1
Visits to centre 899 842 −6.3
Home visits 749 656 −12.4
Contacts with local accident and
emergency departments (24 h)
6 397 6 153 −3.8
Calls to NHS Direct North East 10 122 17 559 73.5
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Should NICE’s advice be
handled centrally or locally?
Editor—Smith’s editorial on the failings of
the National Institute for Clinical Excellence
(NICE) addresses the right issue but attacks
the wrong target.1 It is not the recommenda›
tions emanating from the institute’s delib›
erations that have an impact on the NHS but
the subsequent executive letter that issues
from the Department of Health.
The institute has many strengths, but its
remit is weak in at least four areas2:
x It often has to rely on evidence from stud›
ies whose criteria on patient selection exclude
people at the extremes of age, non›compliant
people, and those with comorbidity
x Economic appraisal is a factor in its
assessments. In complex interventions,
sweeping generalisations have to be made
about typical costs in typical hospitals and
typical clinical outcomes in a range of treat›
ment centres and populations. At local level
the costs (especially marginal costs and
opportunity costs) and outcomes can be
very different from the norm. Briggs, in the
editorial preceding Smith’s, warns of trials
that are underpowered with respect to
economic variables3
x The institute usually looks at a single link
in a patient pathway, and the Department of
Health translates its recommendations into
requirements. But in a local health economy
the more pressing bottlenecks in the
patient’s journey might be at the diagnostic
stage or in palliative care
x The institute does not have to consider
trade offs within whole programmes of care,
such as women’s health. The forthcoming
review of infertility treatments will be a fasci›
nating worked example. In east Norfolk last
year we lengthened screening intervals for
cervical cancer from 36 months to 54
months, at a small but tangible health loss.
But we are now able to sustain our substan›
tial in vitro fertilisation programme as well
as allow sterilisations on the NHS, giving a
favourable net health gain; this has been
supported at public consultation. A neigh›
bouring health authority claims that in vitro
fertilisation and sterilisations are unafford›
able and continues its 36 month cervical
screening cycle.
The job of the National Institute for
Clinical Excellence is not to ration but to
advise. The institute works best at arm’s
length. Smith’s Committee for Honest and
Open Rationing is the Department of
Health. The real debate is whether open›
ness, honesty, and responsibility should be
handled centrally (on the assumption that
the centre always knows best and one size fits
all) or delegated to local level, where we
would celebrate the differences that
emerged as an indicator of a lively and
responsive NHS. I prefer the latter.
Peter Brambleby consultant in public health
Norfolk Health Authority, Thorpe St Andrew,
Norwich NR7 0HT
peter.brambleby@norfolk.nhs.uk
Competing interests: The author has participated in
several public and professional educational events
on health economics, including support for the case
for health authority funding of infertility within the
NHS, sponsored by a variety of pharmaceutical
companies, notably Serono, Bristol Myers›Squibb,
Zeneca, Novartis, and Janssen›Cilag.
1 Smith R. The failings of NICE. BMJ 2000;321:1363›4.
(2 December.)
2 Brambleby P. How to get NICE drugs funded: Cancer
services insight; Aug 2000; Available at www.totalhealth›
caremedia.com (accessed 15 Feb 2001).
3 Briggs A. Economic evaluation and clinical trials: size
matters. BMJ 2000;321:1362›3. (2 December.)
Catheter ablation for cardiac
arrhythmias
Ablation should not be denied to elderly
patients on basis of age
Editor—Peters in his editorial fails to justify
his conclusion that older patients with long›
standing atrial fibrillation can be managed
by controlling their ventricular rate and by
giving them anticoagulation treatment with›
out need for input from a specialist.1 Elderly
people are underrepresented in clinical
trials of cardiovascular disease and are less
likely to have appropriate cardiological
investigations.2 3
The reason for valuing the life of
younger patients over that of older ones is
not made explicit. Harris argues that what is
valued by each of us is the rest of our lives,
the duration of which is unknown.4 An anti›
ageist argument is of particular relevance to
catheter ablation, a procedure that is
applicable to patients of all ages and consid›
ered by some to be first line treatment in
selected elderly patients.5 If catheter ablation
is denied to elderly patients on the basis of
age then they are subject to the same injus›
tice as if the procedure had been denied to
the young on some equally spurious
premise.
David Bourne specialist registrar geriatric medicine
Department of Elderly Medicine, Manchester Royal
Infirmary, Manchester M13 9WL
davidr.bourne@doctors.org.uk
1 Peters NS. Catheter ablation for cardiac arrhythmias. BMJ
2000;321:716›7. (23 September.)
2 Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly
people from clinical research: a descriptive study of
published reports. BMJ 1997;315:1059.
3 Bowling A, Ricciardi G, La Torre G, Boccia S, McKee D,
McClay M, et al. The effect of age on the treatment and
referral of older people with cardiovascular disease
[abstract]. J Epidemiol Commun Health 1999;53:658.
4 Harris J. The value of life. London: Routledge, 1985.
5 Van Gelder IC, Brugemann J, Crijns HJ. Pharmacological
management of arrhythmias in the elderly. Drugs Aging
1997;11:96›110.
Author’s reply
Editor—Bourne seems to make an assump›
tion that is common in clinical practice, of
considering older patients with atrial fibrilla›
tion to encompass all elderly patients with
an arrhythmia. Not all complaints of
palpitations and irregularities of the pulse in
elderly people can be assumed to be atrial
fibrillation.
Atrial fibrillation is recognised to be
common and a major clinical challenge
among elderly people (affecting 9% of those
older than 70 years), but other arrhythmias
must be considered, particularly atrial flutter
or the possibility of ventricular tachycardia,
if there is evidence of previous myocardial
infarction. Although they are considerably
less likely than atrial fibrillation, other
arrhythmias such as these for which
radiofrequency ablation may be appropriate
are not uncommon in this age group. For
older patients with longstanding atrial fibril›
lation, Bourne’s assertion that the paper by
Van Gelder et al concludes that radio›
frequency ablation should be first line treat›
ment is incorrect. In chronic atrial fibrilla›
tion, radiofrequency ablation cannot be
considered first line treatment to abolish the
arrhythmia in any age group. If, however,
control of the ventricular rate cannot be
achieved by other means, radiofrequency
ablation of the atrioventricular node accom›
panied by implantation of a ventricular
pacemaker may provide appropriate symp›
tomatic relief.
I thank Bourne for the opportunity to
raise these important issues in response to
his drawing ageist conclusions from the edi›
torial. In so doing, however, he seems to
have missed the point.
Nicholas S Peters professor of cardiac
electrophysiology
Department of Cardiology, St Mary’s Hospital and
Imperial College School of Medicine, London
W2 1NY
npeters@ic.ac.uk
Surveillance of Haemophilus
influenzae infection
Surveillance data for assessing impact of
vaccination are valid
Editor—Olowokure et al suggest that
routine surveillance of Haemophilus influen›
zae is incomplete, that completeness
declined after the vaccine was introduced,
and that the effectiveness of vaccination pro›
grammes is overestimated.1 We question this.
The authors suggest that the same weak›
ness may affect the surveillance of the group
C meningococcal vaccination programme.
We accept that routine reporting is often
incomplete, but, because of this, all vaccine
preventable infections are under enhanced
surveillance. The 15›fold reduction in the
incidence of H influenzae type b disease after
the introduction of the H influenzae type b
vaccine was observed in an enhanced active
surveillance scheme operating in five NHS
regions,2 not by the use of routine laboratory
reports to the Public Health Laboratory
Service (PHLS) Communicable Disease
Surveillance Centre.
This surveillance scheme was estab›
lished before the vaccine was introduced
and was continued until 1995, when an
enhanced national scheme was imple›
mented.3 Completeness of data can be max›
imised by reconciling reports to the
Communicable Disease Surveillance Cen›
tre, isolates referred to the PHLS Haemo›
philus Reference Unit, and notifications of H
influenzae type b meningitis, and by active
reporting of cases to the British Paediatric
Surveillance Unit.
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A similar scheme—reconciling reference
laboratory reports, notified infections, cases
known to consultants in communicable dis›
ease control, and laboratory reports to the
Communicable Disease Surveillance
Centre—was used to determine the burden
of infection before the introduction of
meningococcal group C vaccine4; this
scheme has now been extended nationally.
Olowokure et al do not mention the
most important weakness of surveillance
systems for vaccine preventable disease.
When the incidence of a disease is being
ascertained after the introduction of a
vaccine, the specificity of clinical case defini›
tions and laboratory tests is critical. If
specificity is low, when the true incidence of
an infection declines the predictive value of
the case definition falls and the proportion
of false positive diagnoses increases.
Since 1990 in five regions, and since
1995 in the whole of England, all reports of
confirmed invasive haemophilus infections
have been followed up by referral of the iso›
late to the PHLS Haemophilus Reference
Unit, where additional confirmation is
carried out with molecular typing tech›
niques. Between 1995 and 1999, of 136
putative type b isolates referred, only 108
were confirmed as type b.
The evaluation of surveillance data for
H influenzae type b vaccine should be based
only on confirmed type b infections. The
collaboration between the Communicable
Disease Surveillance Centre and the
national reference laboratories for menin›
gococcal and haemophilus infections
ensures that national surveillance data for
England and Wales for assessing the impact
of vaccination are valid.
Mary Ramsay consultant epidemiologist
PHLS Communicable Disease Surveillance Centre,
London NW9 5EQ
mramsay@phls.org.uk
Mary Slack consultant microbiologist
PHLS Haemophilus Reference Unit, John Radcliffe
Hospital, Oxford OX3 9DU
Edward Kaczmarski consultant microbiologist
PHLS Meningococcal Reference Unit, Withington
Hospital, Manchester M20 2LR
1 Olowokure B, Hawker J, Blair I, Spencer N. Decrease in
effectiveness of routine surveillance of Haemophilus influ›
enzae disease after introduction of conjugate vaccine:
comparison of routine reporting with active surveillance
system. BMJ 2000;321:731›2. (23 September.)
2 Hargreaves R, Slack M, Howard A, Anderson E, Ramsay M.
Changing patterns of invasive haemophilus influenzae
diseases in England and Wales after introduction of the
Hib vaccination programme. BMJ 1996;312:160›1.
3 Invasive Haemophilus influenzae infections: changing
patterns. Commun Dis Rep 1994;4:227.
4 Enhanced surveillance of meningococcal disease. Commun
Dis Rep 1998;8:1
Authors’ reply
Editor—Ramsay et al misrepresent the
conclusions of our study. We suggested that
routine surveillance was incomplete, that the
underascertainment worsened after the vac›
cine was introduced, and that if routine sur›
veillance data are used the effectiveness of
the vaccine is overestimated. Thus we make
the argument for the introduction of
enhanced surveillance before the introduc›
tion of the intervention (to set baselines) and
its continuation, with the same methods,
after the introduction (to detect change).
At the time that we performed our
analysis the relevance to the introduction of
meningococcal type C vaccine was that no
funding had been agreed for ongoing
enhanced meningococcal surveillance, even
though the immunisation programme had
started. Enhanced national surveillance has
now been set up, although there are
methodological differences to the sub›
national system that was in place before the
vaccine was introduced.
Because our paper was published as a
short report (maximum 600 words) we did
not have space to mention several weaknesses
in surveillance systems. The use solely of
laboratory confirmed cases obtained by
testing routinely generated clinical specimens
presupposes that no changes occur in the
clinical practice that generates these isolates.
Experience with meningococcal infection
suggests that preadmission antibiotics and an
increased reluctance to perform lumbar
puncture in recent years have reduced the
likelihood of obtaining an isolate of the
infecting organism1 and that other methods
of case ascertainment are required.2
Ramsay et al, and others, expend
enormous effort in improving surveillance
data. They should interpret our report as
supportive of the need for their efforts.
Babatunde Olowokure specialist registrar, public
health medicine
Section of Child Health, School of Postgraduate
Medicine, University of Warwick, Coventry
CV4 7AL
bolowokure@cdscwmid.demon.co.uk
Jeremy Hawker consultant epidemiologist
Department of Public Health and Epidemiology,
University of Birmingham, Birmingham B15 2TT
1 Hawker JI, Olowokure B, Parr L. Enhanced surveillance of
meningococcal disease in the West Midlands: 1996 to
1998. Commun Dis Public Health 1999;2:269›72.
2 Kaczmarski E, Cartwright KAV. Control of meningococcal
disease: guidance for microbiologists. Commun Dis Rep
CDR Rev 1995;5:R196›8.
Outcome of pregnancy in
diabetic women
Authors did not define criterion for case
selection
Editor—Hawthorne et al claim to show that
women with diabetes have a much more
unfavourable outcome of pregnancy in
England than Norway.1 But what does their
study really show?
Their criterion for case selection
(“diabetes”) was not defined. But the
prevalence differs hugely between the coun›
tries: 1 in 335 pregnant women in northeast
England and 1 in 90 in Norway were
reported to have diabetes. This suggests that
selection in the two countries was based on
different clinical criteria. In northeast Eng›
land most women included in the northern
diabetic pregnancy survey were taking insu›
lin before pregnancy, and all cases were con›
firmed by the clinicians and from the patient
record.2 The data from Norway are from the
centralised medical birth registry, and the
possible pitfalls of this are illustrated by
experience in Scotland.
I checked national registry listings of
diabetes as part of the protocol for the SIGN
(Scottish Intercollegiate Guidelines Net›
work) guideline on management of preg›
nancy.3 Some women recorded as having
diabetes did indeed have this, but some had
only impaired glucose tolerance; some had
had a glucose tolerance test but the result
was normal; some had only a relative with
diabetes; and some did not have diabetes,
had not had a glucose tolerance test, and did
not have a relative with the condition. Even if
the diagnosis in the Norwegian registry was
always reliable and was recorded before
pregnancy, as stated, here is one further spe›
cific source of possible systematic error.
Women who did not have type 1 or type
2 diabetes but who had had an abnormal
result of a glucose tolerance test during a
previous pregnancy may have been included
as cases. The higher the proportion of
women without diabetes in the case group
the better the outcome will be.
The outcome of pregnancy may be
better in Norway, but this comparison looks
flawed. The authors need to define the con›
dition to be studied to ensure that data
assembly includes only those cases, and thus
like is compared with like.
Frank Johnstone senior lecturer
Department of Obstetrics and Gynaecology,
University of Edinburgh, Centre for Reproductive
Biology, Edinburgh EH3 9ET
fdj@srv1.med.ed.ac.uk
1 Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy
in diabetic women in northeast England and in Norway,
1994›7. BMJ 2000;321:730›1. (23 September.)
2 Hawthorne G, Robson S, Ryal EA, Sen D, Roberts SH,
Ward Platt MP. Prospective population based survey of
outcome of pregnancy in diabetic women; results of the
northern diabetic pregnancy audit, 1994. BMJ 1997;315:
279›81.
3 Scottish Intercollegiate Guidelines Network. Management
of diabetes in pregnancy. Edinburgh: SIGN, I996. (SIGN
guideline No 9.)
More investigation is needed into
whether control of diabetes is really
poorer in England than Norway
Editor—Hawthorne et al compared the
outcome of pregnancy in women with
pregestational diabetes between northeast
England and Norway.1 They note a wide dis›
crepancy in both perinatal mortality and
congenital defects, with Norway having
much lower rates of adverse outcome than
northeast England. They state that the regis›
tration system in Norway results in identical
data being collected in the two countries.
Apparent from the table—but not
commented on by the authors—is the
striking contrast in prevalence of maternal
diabetes between the two countries: 0.3%
(304/101 516) in northeast England and
1.1% (2019/179 754) in Norway. This raises
the question as to whether this difference is a
true reflection of the prevalence in the two
countries. There are at least four possible
alternative explanations: the Norwegian
data include data for cases of gestational
diabetes and the English data are for only
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cases of more severe uncontrolled diabetes;
the Norwegian data have a higher rate of
keying or editing errors (which will serve to
increase the apparent numbers with a rare
disorder and dilute any effect); the Norwe›
gians do have a higher rate of diabetes in
young women; or the criteria for diagnosis
differ between the two countries.
We hope that these four possibilities will
be investigated before any conclusion is
reached on poorer control of diabetes caus›
ing an excess of problems in the United
Kingdom. We have strong reasons to think
that the English data on prevalence are
accurate since data from the prospective
Avon longitudinal study of parents and chil›
dren show a similar rate (0.4%) of pregnan›
cies in women with non›gestational diabetes
to that in Hawthorne et al’s study.2
Jean Golding professor of paediatrics and perinatal
epidemiology
Division of Child Health, University of Bristol,
Bristol BS8 1TQ
For the ALSPAC (Avon Longitudinal Study of
Parents and Children) Study Team
1 Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy
in diabetic women in northeast England and in Norway
1994›7. BMJ 2000;321:730›1.
2 Golding J, Pembrey M, Jones R, ALSPAC Study Team.
ALSPAC—the Avon longitudinal study of parents and
children. I. Study methodology. Paediatr Perinat Epidemiol
2001;15:74›87.
Authors’ reply
Editor—Johnstone suggests that the case
selection for diabetes was not defined and
that this invalidates the finding that the out›
come of pregnancy is better in Norway than
northeast England. He acknowledges that
diabetes was confirmed in most cases from
northeast England before entry into the
study, but he questions the data from
Norway. Golding et al draw attention to the
contrast in prevalence of maternal diabetes
between the two countries and suggest pos›
sible explanations for this.
We accept that there are pitfalls in using
centralised data. However, data collection by
the medical birth registry in Norway has
documented a decline in perinatal mortality
for diabetic pregnancy, from 155.1/1000 for
1967›72 to 18.1/1000 for 1986›92.1 During
this time the number of births delivered in
hospitals with more than 3000 births a year
has increased from less than 10% to 34%.
During the 1990s gestational glucose
intolerance was a particular focus in clinical
work as well as in the registration. This has
ensured the option of removing cases of
gestational glucose intolerance from the
analysis. The fact that there has been no
secular decrease in the occurrence of
macrosomia in the infants adds to the valid›
ity of the diagnoses registered by the
medical birth registry.2
There are clear clinical guidelines
recommending centralisation of clinical care
of diabetic pregnancy. These guidelines
distinguish the management of diabetes and
glucosuria during pregnancy.3 The
improved mortality figures are thought to
relate to an updated intensified follow up
module for pregnant diabetic patients,
improved diabetes care in general, home
glucose monitoring, and measurement of
haemoglobin A1c concentrations.
Norway has a documented high and
increasing incidence of diabetes in children4
and young people.5 In 1991 Joner and Sovik
showed that there was a twofold increase in
the incidence of diabetes mellitus in the
15›29 year age group.5 The finding that
there is an increased prevalence of diabetic
pregnancies in Norway compared with
northeast England is consistent with these
data.
Gillian Hawthorne consultant paediatrician
Northern Diabetic Pregnancy Survey, Regional
Maternity Survey Office, Newcastle upon Tyne
NE2 4AA
gillian.hawthorne@nth.northy.nhs.uk
L M Irgens professor
R T Lie professor of medical statistics
Medical Birth Registry of Norway, Hauletend
Hospital, N›5021 Bergen, Norway
1 Jervell J, Magnus P, Moe N, Bakketeig LS, Halse J. Resulta›
tet av svangerskap hos diabetikere. Utviklingen I Norge fra
1967 til 1990. (Pregnancy outcome in diabetics.) Norsk
Epidemiloogi 1994;4:34›5.
2 Hellesen HR, Vikane E, Lie RT, Irgens LM. Maternal
diabetes–normalised perinatal mortality, but still high fetal
growth. Tidsskr Nor Laegeforen 1996;116:3465›9. (In
Norwegian.)
3 Dalaker K, Berle EJ, eds.Clinical guidelines in obstetrics 1999.
Oslo: Norwegian Medical Association, 1999.
4 Joner G, Sovik O. Increasing incidence of diabetes mellitus
in Norwegian children 0›14 years of age 1973›1982.Diabe›
tologia 1989;32:79›83.
5 Joner G, Sovik O. The incidence of type 1 (insulin›
dependent) diabetes mellitus 15›29 years in Norway 1978›
1982. Diabetologia 1991;34:271›4.
Ultrasonography in diagnosis
of acute appendicitis
Diagnostic laparoscopy is often more
useful than ultrasonography
Editor—Douglas et al’s trial of ultrasonog›
raphy in the diagnosis of acute appendicitis,
and the accompanying editorial, highlight
the importance of an accurate diagnosis of
acute abdominal pain in the right iliac fossa
and the need to avoid unnecessary appendi›
cectomy.1 2 The results indicate that ultra›
sonography has little practical value in the
diagnosis of acute appendicitis because of
false positive and false negative results and
the inability to identify alternative diagnoses.
Neither article mentioned the increasing
use of diagnostic laparoscopy in these cases.
This technique makes an accurate diagnosis
clearly; this is especially useful in female
patients of any age and in elderly men, in
whom diagnostic doubt is common. As well
as preventing inappropriate appendicec›
tomy, diagnostic laparoscopy defines the
correct operative intervention if an alterna›
tive diagnosis necessitates surgery. If surgery
is not required a definitive management
plan is usually clear. A further advantage of
laparoscopy is that if surgeons have appro›
priate training and experience the appendix
can be removed laparoscopically, with
advantages in patient recovery.3
If the abdominal signs are sufficiently
clear to indicate peritonism in the right iliac
fossa in elderly patients or female patients of
reproductive age there is little to be gained
from ultrasonography. Laparoscopy should
be undertaken and surgical intervention
proceeded to as appropriate.
Stephen Attwood consultant surgeon
Hope Hospital, Salford Royal Hospitals NHS Trust,
Salford M6 8HD
Jridgeway@Hope.srht.nwest.nhs.uk
1 Douglas CD, Macpherson NE, Davidson PM, Gani JS. Ran›
domised controlled trial of ultrasonography in diagnosis
of acute appendicitis, incorporating the Alvarado score.
BMJ 2000;321:919›22. (14 October.)
2 Beasley SW. Can we improve diagnosis of acute appendici›
tis? BMJ 2000;321:907›8. (14 October.)
3 Attwood SEA, Hill ADK, Murphy PG, Thornton J,
Stephens RB. A prospective randomised trial of laparo›
scopic versus open appendectomy. Surgery 1992;112:
497›501.
Active observation is often sufficient to
make diagnosis
Editor—Douglas et al have added to the
debate on the role of imaging in the diagno›
sis of acute appendicitis.1 Reasons for using
ultrasound, and perhaps computed tomog›
raphy, need to be viewed against the
background of the epidemiology of acute
appendicitis.
When all children admitted with acute
abdominal pain were studied in the 1960s it
was found, surprisingly, that in 30›40%
(mostly referred as having “?acute appendi›
citis”) the condition settled without treat›
ment. This syndrome, which for 12›24 hours
closely resembles acute appendicitis, was
named acute non›specific abdominal pain2
and was soon found to occur equally
commonly in adults.3
The knowledge that as many as one
third of patients with acute abdominal pain
will prove to have a self limiting condition
must have an effect on management. At the
time of admission about one third of
patients clearly need emergency surgery.
Then the task among the remainder is to
distinguish, with the minimum of delay,
those with suspicious signs who are develop›
ing surgical or medical disease requiring
treatment from those with non›specific
abdominal pain.
When the frequency of non›specific
abdominal pain is not allowed for there is a
tendency to regard every doubtful case as a
possible perforated appendix, and this still
leads to as many as 15›30% of appendicec›
tomies being unproductive. If a policy of
active observation is adopted, experience
over 25 years in many centres has shown
that repeated bedside examination is a safe
method of separating the two groups; an
unproductive appendicectomy rate of 14%
in the 1960s had fallen to 3›5% in the
1990s.4 Concern is expressed that delay
during observation allows perforation to
occur, but most patients with a perforated
appendix show appreciable signs on admis›
sion; recovery has been good in the few
cases that have been recognised during
active observation.4
The existence of imaging (especially
computed tomography, with its high dose of
radiation) is not a reason for using it if a
simpler method is effective and safe, and
experience with active observation suggests
that it is rarely required. Douglas et al and
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Weyant et al5 have found that reliance on
ultrasound and computed tomography
produces problems from false negative and
positive results that have to be resolved at
the bedside; both groups emphasise the
central role of “more precise patient
selection by clinical criteria.”5
Peter F Jones emeritus clinical professor of surgery
University of Aberdeen, Aberdeen AB15 9HR
timruth.jones@btinternet.com
1 Douglas CD, Macpherson NE, Davidson PM, Gani JS. Ran›
domised controlled trial of ultrasonography in diagnosis
of acute appendicitis, incorporating the Alvarado score.
BMJ 2000;321:919›22. (14 October.)
2 Jones PF. Acute abdominal pain in childhood, with special
reference to cases not due to acute appendicitis. BMJ
1969;i:284›6.
3 De Dombal FT, Leaper DJ, Staniland JR, McCann AP, Hor›
rocks JC. Computer›aided diagnosis of acute abdominal
pain. BMJ 1972;ii:9›13.
4 Jones PF, Bagley FH. Acute appendicitis. In: Jones PF, Kru›
kowski ZH, Youngson GG, eds. Emergency abdominal
surgery. 3rd ed. London: Chapman and Hall, 1998:48›52.
5 Weyant MJ, Eachempati SR, Maluccio MA, Rivadeneira
DE, Grobmyer SR, Hydo LJ, et al. Interpretation of
computed tomography does not correlate with laboratory
or pathologic findings in surgically confirmed acute
appendicitis. Surgery 2000;128:145›52.
Interrupting antiretroviral
treatment needs particular care
Editor—Noble and Kehlet raise an impor›
tant issue in their editorial about the
interruption of drug treatment during the
postoperative period.1 We would emphasise
the particular problems of drug interrup›
tions in HIV infected patients receiving
combination antiretroviral treatment; in
these patients the general rule that some
drugs are better than none does not apply.
Efavirenz and nevirapine are both
non›nucleoside reverse transcriptase inhibi›
tors with long plasma half lives (44›55 hours
and 25›30 hours respectively) relative to the
other main classes of antiretroviral drugs
(nucleoside reverse transcriptase inhibitors
(1›6 hours) and protease inhibitors (1›7
hours)).2 Thus if a patient is taking efavirenz
or nevirapine as part of his or her HIV treat›
ment in combination with two nucleoside
reverse transcriptase inhibitors, and all the
drugs are stopped at the same time, the long
half lives of the inhibitors will result in a
period of monotherapy with these agents
perioperatively.
A similar situation may arise when
antiretroviral drugs with dietary restrictions
(for example, indinavir, nelfinavir, didanos›
ine) are stopped earlier or restarted later in
the perioperative period than other drugs in
the regimen without such restrictions (for
example, stavudine, lamivudine, zidovudine,
nevirapine, efavirenz). HIV›1 has a rapid
mutation rate, and so even brief periods of
monotherapy may result in the rapid
accumulation of drug resistant strains and
loss of virological control (L Guay et al, sev›
enth conference on retroviruses and oppor›
tunistic infections, San Francisco, 2000;
abstract S12). This is a particular problem
for antiretroviral drugs with a low genetic
barrier (such as efavirenz, nevirapine, lami›
vudine), where a single mutation may result
in phenotypic resistance.3
If possible, antiretroviral treatment
should not be interrupted in patients under›
going general anaesthesia or other proce›
dures for which they must be nil by mouth
for a period. When an interruption is
unavoidable all antiretroviral drugs should
be stopped and restarted together, except
for those with a long half life, which should
be stopped two to four days before the oth›
ers. We recommend that specialist HIV
advice should be sought about antiretroviral
management in individual patients.
W A C Sewell specialist registrar
C Mazhude specialist registrar
A Murdin›Geretti lecturer
S Jones senior pharmacist
P J Easterbrook professor
philippa.easterbrook@kcl.ac.uk
Academic Department of HIV/Genitourinary
Medicine, Guy’s, King’s and St Thomas’s School of
Medicine, Weston Education Centre, London
SE5 9RT
1 Noble DW, Kehlet H. Risks of interrupting drug treatment
before surgery. BMJ 2000;321:719›20. (23 September.)
2 Samuel R, Suh B. Antiretroviral therapy 2000. Arch Pharm
Res 2000;23:425›37.
3 Nijhuis M, Schuurman R, de Jong D, Erickson J, Gustchina
E, Albert J, et al. Increased fitness of drug resistant HIV›1
protease as a result of acquisition of compensatory muta›
tions during suboptimal therapy. AIDS 1999;13:2349›59.
Smoking and use of mobile
phones
Data have been wrongly interpreted
Editor—Charlton and Bates’s use of data
was breathtaking in its inaccuracy.1 For a
start, the chart has no data points before
1996, so we have no way of judging how
large the downturn in teenage smoking has
been. But more importantly, the chart shows
clearly that teenage smoking was falling
before the sharp rise in mobile phone own›
ership. And, even worse, at the point where
phone ownership sharply increases, the
decline in smoking actually levels off.
This is a clear case of not letting the facts
get in the way of an interesting hypothesis. It
is even more regrettable given that the letter
caught the national headlines. This sad mis›
use of numbers is a great deal worse—
because it is so obvious—than the more
technical statistical liberties I often find in
BMJ articles.
Trevor Jones managing director
Marketing Databasics, Links House, Edinburgh
trevor.jones@marketingdatabasics.com
1 Charlton A, Bates C. Decline in teenage smoking with rise
in mobile phone ownership: hypothesis. BMJ
2000;321:1155. (4 November.)
Italian data don’t show the same pattern
Editor—The hypothesis of a beneficial effect
of mobile phones on adolescents’ attitudes to
smoking is appealing, and the explanations
suggested by Charlton and Bates are attrac›
tive.1 Italians lead the European Union in
ownership of mobile phones, so the influ›
ences of this particular social habit on
teenage behaviour could be studied appro›
priately in our country.
However, data from the Italian Institute
for Statistics do not suggest a decrease in the
prevalence of smoking among people aged
15›24 in Italy (table). On the contrary,
although rates of smoking among boys seem
to be stable, rates in girls have been rising
during 1995 to 1998.2 3 Only a survey
intended specifically to study the possible
correlations between smoking and use of
mobile phones will be able to verify this
interesting hypothesis.
Giovanni Invernizzi head, tobacco control team
Respiratory Branch, Italian College of General
Practitioners, Milan, Italy
ginverni@clavis.it
Roberto Boffi consultant
Roberto Mazza nurse
Smoke›free Institute, National Cancer Institute,
Milan, Italy
Paolo Paredi clinical and research fellow
National Heart and Lung Institute, London
1 Charlton A, Bates C. Decline in teenage smoking with rise
in mobile phone ownership: hypothesis. BMJ 2000;321:
1155. (4 November.)
2 Italian Institute for Statistics. Annual report 1998. Rome:
ISTAT, 1999.
3 Pagano R, La Vecchia C, Decarli A. Smoking in Italy, 1995.
Tumori 1998;84:456›9.
No correlation in Switzerland either
Editor—The link between smoking and use
of mobile phones by young people sug›
gested by Charlton and Bates is not
supported by Swiss data.1 The prevalence of
smokers aged between 15 and 24 in Switzer›
land increased disproportionately between
1992 and 1997 (table). The number of
mobile phone subscribers increased from
215 000 in 1992 to 1 044 000 in 1997. Even
though I do not have the specific numbers
for the age group 15 to 24 year olds, it is
likely that there was at least a proportional, if
not even more rapid, growth in this age
group.
This question should be resolved
through a prospective study in which other
known promoters and demoters of smoking
in various countries are considered together
with use of mobile phones.
Chung›Yol Lee research associate
Institute of Social and Preventive Medicine,
University of Zurich, Switzerland
yol@ifspm.unizh.ch
Percentage of smokers among Italians aged
15›24 years in 1995 and 1998*
1995 1998
Male 27.7 26.2
Female 12.7 15.4
Proportion of population that smokes and
ownership of mobile phones in Switzerland 1992
and 1997
1992 1997
Smokers of all ages2 30.1% 32.7%
Smokers aged 15›24 31% 43%
No of mobile phone
owners3
215 000 1 004 000
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1 Charlton A, Bates C. Decline in teenage smoking with rise
in mobile phone ownership: hypothesis. BMJ 2000;321:
1155. (4 November.)
2 Swiss Federal Office of Statistics. Swiss national health sur›
vey 1997. www.statistik.admin.ch/news/pm/dp98108.htm
(accessed 8 November 2000).
3 Telecommunication Statistics 2000›1. Swiss Telecommuni›
cations Market: Evolution of the infrastructure. Available at
www.bakom.ch/ger/subsubpage/docs/1366/# (accessed
8 Nov 2000).
Hospital mergers may be
painful but have positive
aspects too
Editor—Most of us would agree with
Harvey’s comments in her personal view
about the problems of hospital mergers.1 A
merger is more like a divorce than a
marriage. It introduces vulnerabilities, sensi›
tivities, suspicion, and redirections that often
seem inappropriate.
The developing paranoia that Harvey
expresses—concerning the perceived low
morale and poor standards of the interlop›
ing hospital—is only too common. It is over›
come by communication and joint decision
taking, which, in itself, is extremely difficult,
not only because of the separation of the
units but also because of the lack of time in
one’s clinical practice.
There is, though, a positive side to a
merger. The larger population that we serve
allows a more efficient use of resources, par›
ticularly in smaller specialties. Merged
departments allow a more efficient use of
junior hospital doctors, especially specialist
registrars; this is a bonus in view of both the
European directive to reduce their hours
and the reduction in Calman numbers. The
Royal College of Obstetricians and Gynae›
cologists has considered the increasing risk
in obstetric practice, litigation, governance,
and training of junior hospital doctors.2 In
addition it is implementing standards that
include 40 hours a week of consultant pres›
ence on labour wards and a delivery rate per
consultant that falls from the national yearly
average of 543 to 300.2
The surgical process of the merger
might be painful but the improved health
care of patients and quality of practice
should make it worth while.
A J Minchin consultant obstetrician and gynaecologist
Chase Farm Hospital, Enfield, Middlesex EN2 8JL
1 Harvey D. Hospital games. BMJ 2000;321:713. (16
September.)
2 Royal College of Obstetricians and Gynaecologists Work›
ing Party. Planning for the future as consultants in obstetrics
and gynaecology. London: RCOG, 1999.
The fragile male
Male zygotes are often formed at
suboptimal times in fertile cycle
Editor—Kraemer adduced large quantities
of data to substantiate the proposition that,
from conception, males are more vulnerable
than females.1 Postnatal vulnerability has
some social causes, which are known, but the
causes of the prenatal vulnerability of males
are not established, so I wish to suggest one.
During the menstrual cycle women have
a fertile window lasting several days.2 There
is strong direct3 and indirect4 evidence that
the regression of the sex ratio of the
offspring (proportion male) on the time of
fertilisation is U shaped across this fertile
window. In other words, females are formed
disproportionately often in the middle of
this window and males at either end of it.
There is also strong evidence that zygotes
formed at either end of the window are
more likely to be spontaneously aborted.5
Thus it would seem that, compared with
female zygotes, male zygotes are formed dis›
proportionately often at suboptimal times in
the cycle. This suggestion would explain
three factors: the additional prenatal vulner›
ability of males, the suspected higher sex
ratio in spontaneously aborted fetuses than
in live births, and the male excesses in those
adult diseases suspected of being related to
suboptimal intrauterine environments.
William H James honorary research fellow
Galton Laboratory, University College London,
London NW1 2HE
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Men should follow example of women’s
health movement
Editor—As Kraemer points out, being a
man can seriously damage your health.1 The
Men’s Health Forum (www.menshealthforu›
m.org.uk), with a membership of over 180
organisations ranging from the BMA and
the Department of Health to the Royal Col›
lege of Nursing, and from the Post Office to
Marks and Spencer, has campaigned on this
issue for six years. Politicians now seem to
realise that men’s health is often a contradic›
tion in terms and urgently needs more
attention and resources.
Extensive research shows that the health
of both sexes is often inextricably entwined;
this is clearly shown by chlamydial infection.
A joint approach to the health of women
and men is required, rather than a “them
and us” confrontation.
It is no coincidence that men’s health is
increasingly highlighted in areas where
women are taking their place as policymak›
ers. Half of the elected representatives of the
Men’s Health Forum are female, with a
woman as deputy chair. It was two women—
Tessa Jowell and Yvette Cooper (minister for
public health and minister for health,
respectively)—not Frank Dobson or Alan
Milburn (previous and current health secre›
taries) who brought men’s health as an issue
to the attention of parliament.
Perhaps men should take a leaf from the
women’s health movement’s book rather
than begrudge women their success. With
spending on women’s health in the United
Kingdom the lowest in Europe, it would
serve both sexes well to improve spending
generally in the NHS.
Ian Banks chairman
Men’s Health Forum, London WC1H 9JP
ian@medic40.freeserve.co.uk
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Title of Dr should be sufficient
for all doctors
Editor—I applaud Loudon’s questioning of
the title of Mr for surgeons,1 but he is much
too gentle with our sensitive colleagues. My
history genes could grudgingly accept Mr
for male consultant surgeons, but the
absurdity is complex.
Married multiparous surgeons are usu›
ally referred to as Miss, a title more
appropriate to an actress than a doctor.
Gynaecologists and ophthalmologists are
Dr in Scotland but Mr or Miss in England
and Wales. Patients, who erroneously con›
sider that all consultants are Mr or Miss,
become confused when a young surgical
senior house officer or registrar converts
overnight from being addressed as Dr to
being addressed as Mr or Miss on passing
the fellowship of the Royal College of
Surgeons.
I have no doubt that some patients fret
with anxiety over getting the great man’s (or
woman’s) title right. I am a physician, and I
well recall one of my elderly patients
whispering to her husband as she left my
consulting room, “He was Dr Crisp, not Mr
Crisp. He must be one of them junior
doctors.”
British medicine makes itself ridiculous
with its multiplicity and inconsistency of
titles for practising doctors. The title Dr
should be sufficient for all doctors regardless
of age, sex, specialty, and distinction. I
applaud the North American practice of
preferring to use the title Dr rather than
Professor when treating patients.
A J Crisp consultant
Department of Rheumatology, Addenbrooke’s
Hospital, Cambridge CB2 2QQ
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